NCT00690755View on ClinicalTrials.gov

Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic Syndrome

CompletedOBSERVATIONAL
Enrollment

157

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Diabetes Mellitus, Type 2
Trial Locations (1)

33612

VA Medical Center, Tampa

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT00690755 - Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic Syndrome | Biotech Hunter | Biotech Hunter